Abstract
Since most of the pathogenic microbes have developed resistance against chemical drug derivatives therefore need of the hour is to formulate plant based natural medicines. These formulations with no or least toxicity can prove better alternative of synthetic drugs. Ethnopharmacologists, botanists, microbiologists, and natural-products chemists are combing the earth for phytochemicals and “leads” which could be developed for the treatment of infectious diseases. While, 25 to 50% of current pharmaceuticals are derived from plants, none are used as antimicrobials. Traditional healers have long used plants to prevent or cure infectious conditions; western medicine is trying to duplicate their successes. Plants are rich in a wide variety of secondary metabolites, such as tannins, terpenoids, alkaloids, and flavonoids, which have been found in vitro to have antimicrobial properties. The present review mainly discusses exploitation of plant secondary compounds as antimicrobial agents. Mode of action of some agents was also addressed. Since many of these compounds are currently available as unregulated botanical preparations and their use by the public is increasing rapidly, clinicians need to consider the consequences of patients self-medicating with these preparations.
Keywords: Natural Drugs, Secondary metabolites, Antimicrobial agents, Botanical preparations, Pharmaceuticals, Plant, Natural product, Phytochemicals, Microbiologists, Synthetic drugs
The Natural Products Journal
Title: Antimicrobial Potential of Botanicals and Disease Control
Volume: 1 Issue: 2
Author(s): Madhu Rathore, Kanika Sharma and Naveen Sharma
Affiliation:
Keywords: Natural Drugs, Secondary metabolites, Antimicrobial agents, Botanical preparations, Pharmaceuticals, Plant, Natural product, Phytochemicals, Microbiologists, Synthetic drugs
Abstract: Since most of the pathogenic microbes have developed resistance against chemical drug derivatives therefore need of the hour is to formulate plant based natural medicines. These formulations with no or least toxicity can prove better alternative of synthetic drugs. Ethnopharmacologists, botanists, microbiologists, and natural-products chemists are combing the earth for phytochemicals and “leads” which could be developed for the treatment of infectious diseases. While, 25 to 50% of current pharmaceuticals are derived from plants, none are used as antimicrobials. Traditional healers have long used plants to prevent or cure infectious conditions; western medicine is trying to duplicate their successes. Plants are rich in a wide variety of secondary metabolites, such as tannins, terpenoids, alkaloids, and flavonoids, which have been found in vitro to have antimicrobial properties. The present review mainly discusses exploitation of plant secondary compounds as antimicrobial agents. Mode of action of some agents was also addressed. Since many of these compounds are currently available as unregulated botanical preparations and their use by the public is increasing rapidly, clinicians need to consider the consequences of patients self-medicating with these preparations.
Export Options
About this article
Cite this article as:
Rathore Madhu, Sharma Kanika and Sharma Naveen, Antimicrobial Potential of Botanicals and Disease Control, The Natural Products Journal 2011; 1 (2) . https://dx.doi.org/10.2174/2210315511101020105
DOI https://dx.doi.org/10.2174/2210315511101020105 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
Call for Papers in Thematic Issues
Ayurvedic medicinal therapeutic approaches for inflammatory and neurodegenerative disorders
Usually, in our elderly population, neurodegenerative disorders occur due to neuron death. Alzheimer?s disease (AD) is an irreversible and progressive neurodegenerative disease. Dementia is the leading cause of AD, which affects about 30 million people worldwide. According to the World Alzheimer report 2018, a new case of dementia develops every ...read more
Recent Advances in Biotransformation of Bioactive Terpenoids using Aspergillus niger
Biotransformation is the reaction catalyzed by biological catalysts of either isolated enzymes or whole cell cultures of microorganisms. This process has been extensively applied in the conversion of bioactive terpenoids with high regio- and stereospecifity. This process has been also applied in the lead discovery and development. Aspergillus niger has ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Patents on Nucleic Acid-Based Antiviral Therapeutics
Recent Patents on Anti-Infective Drug Discovery Suicide and the Polyamine System
CNS & Neurological Disorders - Drug Targets Hypusine Modification of the Ribosome-binding Protein eIF5A, a Target for New Anti-Inflammatory Drugs: Understanding the Action of the Inhibitor GC7 on a Murine Macrophage Cell Line
Current Pharmaceutical Design ETS Proteins and MMPs: Partners in Invasion and Metastasis
Current Drug Targets IN MEMORIAM
Endocrine, Metabolic & Immune Disorders - Drug Targets Meningococcal Disease and Future Drug Targets
CNS & Neurological Disorders - Drug Targets Identification of New Pancreatic Beta Cell Targets for In Vivo Imaging by a Systems Biology Approach
Current Pharmaceutical Design Editorial [Hot topic: Drug Targeting of Autoimmunity (Guest Editor: Manfred Kunz)]
Current Drug Discovery Technologies Evaluation of Skin Permeability of Resveratrol Loaded Liposomes and Nanostructured Lipid Carriers using a Skin Mimic Artificial Membrane (skin-PAMPA)
Drug Delivery Letters The Emergence of Multiplexed Technologies as Diagnostic Platforms in Systemic Autoimmune Diseases
Current Medicinal Chemistry Extracellular Vesicles in the Pathogenesis, Treatment, and Diagnosis of Spinal Cord Injury: A Mini-Review
Current Stem Cell Research & Therapy VEGF Inhibitors in Cancer Therapy
Current Pharmaceutical Design Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral Sclerosis
Current Pharmaceutical Design Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Update on the Therapy of Behçets Disease
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Kynurenine Pathway in Schizophrenia: Pathophysiological and Therapeutic Aspects
Current Pharmaceutical Design New Life to an Old Treatment: Pegylated Interferon Beta 1a in the Management of Multiple Sclerosis
Current Medicinal Chemistry Stem Cells as Delivery Vehicles for Oncolytic Adenoviral Virotherapy
Current Gene Therapy Editorial (Thematic Issue: Challenging Organic Syntheses and Pharmacological Applications of Natural Products and their Derivatives)
Current Pharmaceutical Design Can Lipoprotein-associated Phospholipase A<sub>2</sub> be Used as a Predictor of Long-term Outcome in Patients with Acute Coronary Syndrome?
Current Cardiology Reviews